— Know what they know.
Not Investment Advice

ABAX NASDAQ

Abaxis, Inc.
1W: +0.0% 1M: -0.3% 3M: +19.1% 1Y: +81.1% 3Y: +75.7% 5Y: +113.7%
$83.00
Last traded 2018-08-09 — delisted
NASDAQ · Healthcare · Medical - Equipment & Services

Cash Flow Trends

Operating Cash Flow
$44M +31.3% ▲
5Y CAGR: +8.3%
Capital Expenditures
$6M +40.6% ▲
5Y CAGR: +1.4%
Free Cash Flow
$37M +63.0% ▲
5Y CAGR: +9.7%
Dividends Paid
$14M -16.2% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$45M -1597.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2013FY2014FY2015FY2016FY2017
— Operating Activities —
Net Income$14M$27M$32M$33M$27M
Depreciation & Amort.$7M$8M$7M$7M$7M
Stock-Based Comp.$8M$10M$11M$11M$14M
Change in Working Capital$9M$989K-$22M-$12M$21M
Other Non-Cash Items-$2M-$6M-$1M-$5M-$23M
Operating Cash Flow$36M$36M$28M$33M$44M
— Investing Activities —
Capital Expenditures-$6M-$6M-$5M-$10M-$6M
Acquisitions (Net)$0-$618K-$1M-$4M$0
Investment Purchases-$32M-$37M-$64M-$57M-$109M
Investment Sales$24M$33M$49M$55M$39M
Other Investing$44K$20M$900K$0$3M
Investing Cash Flow-$13M$10M-$20M-$16M-$73M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$3M-$13M-$13M$0$0
Dividends Paid$0-$9M-$10M-$12M-$14M
Other Financing$5M-$5M-$2M-$2M-$3M
Financing Cash Flow-$4M-$11M-$27M-$14M-$16M
Net Change in Cash$19M$33M-$19M$3M-$45M
Cash End of Period$74M$107M$88M$91M$46M
Free Cash Flow$30M$30M$23M$23M$37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms